Sam Brusco, Associate Editor11.27.23
Microline Surgical, a subsidiary of Hoya Corporation, has acquired the rights to certain laparoscopic instrumentation assets from Retraction Limited.
The acquisition includes REVEEL products, which are used for liver retraction in laparoscopic surgeries. REVEEL devices are designed to gently retract the liver with an unobstructed view of the surgical site during a procedures. REVEEL’s patented surface also protects the liver from sliding during surgeries.
REVEEL products are cleared and available for sales in the U.S., UK, and EU.
“We are pleased to announce the signing of this agreement, as the addition of REVEEL to the Microline portfolio enhances Microline’s mission to enable customers to reduce surgical costs and complications, and to improve surgical outcomes,” Microline’s president and CEO Timothy Gehlmann told the press.
“We are thrilled to transfer the rights to our REVEEL Endoscopic Retractor to Microline. Microline is a strong partner, and this transition will enable a greater number of patients and medical practitioners to benefit from our patented technology,” added Stuart Moran, CEO of Retraction Limited.
Microline is a member of the Hoya Group of Life Care companies. The company offers a range of surgical instruments including graspers, dissectors, scissors, and specialized instruments for specific surgical procedures. The company is headquartered in the U.S.
The acquisition includes REVEEL products, which are used for liver retraction in laparoscopic surgeries. REVEEL devices are designed to gently retract the liver with an unobstructed view of the surgical site during a procedures. REVEEL’s patented surface also protects the liver from sliding during surgeries.
REVEEL products are cleared and available for sales in the U.S., UK, and EU.
“We are pleased to announce the signing of this agreement, as the addition of REVEEL to the Microline portfolio enhances Microline’s mission to enable customers to reduce surgical costs and complications, and to improve surgical outcomes,” Microline’s president and CEO Timothy Gehlmann told the press.
“We are thrilled to transfer the rights to our REVEEL Endoscopic Retractor to Microline. Microline is a strong partner, and this transition will enable a greater number of patients and medical practitioners to benefit from our patented technology,” added Stuart Moran, CEO of Retraction Limited.
Microline is a member of the Hoya Group of Life Care companies. The company offers a range of surgical instruments including graspers, dissectors, scissors, and specialized instruments for specific surgical procedures. The company is headquartered in the U.S.